Related Experiment Video
Updated: May 21, 2026
13:07
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
[Turkey's publications in cardiovascular medicine persisted to decrease substantially in 2011]
1Department of Cardiology, Cerrahpaşa School of Medicine, İstanbul University, İstanbul, Turkey. alt_onat@yahoo.com.tr
Summary
Turkey
Area of Science:
- Cardiovascular Medicine Research
- Bibliometrics and Publication Analysis
Context:
- Evaluation of Turkey's scientific output in cardiovascular medicine using Web of Knowledge data from 2011.
- Inclusion criteria focused on full-text articles and reviews indexed in the Science Citation Index CD Edition.
- A fractional counting method was applied for collaborative publications.
Purpose:
- To assess the publication performance of Turkish institutions in cardiovascular medicine.
- To identify trends in research output and its global share.
- To pinpoint leading institutions in the field.
Summary:
- Turkish publications in cardiovascular medicine declined to 101 in 2011, with a reduced global share (5.1 per mille), falling below 2001 levels.
- Adult cardiology accounted for 81 articles, and the median impact factor remained stable at 1.67.
- Key institutions included Kartal Koşuyolu and Türkiye Yüksek İhtisas Hospitals, S. Demirel and Cumhuriyet universities, and Gülhane Military Medical Academy.
Impact:
- The study highlights a concerning decline in Turkey's medical research activity, necessitating urgent policy interventions.
- Findings underscore the need for strategic measures to reverse the downward trend in cardiovascular research output.
- The research provides a benchmark for evaluating national scientific productivity in a critical medical field.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
02:03Anatomy of the Circulatory System
The human circulatory system consists of blood, blood vessels that carry blood away from the heart, around the body, and back to the heart, and the heart itself, which acts as a central pump. The systemic circuit supplies blood to the whole body, the coronary circuit supplies blood to the heart, and the pulmonary circuit supplies blood flow between the heart and lungs.
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...